The Vanguard Group 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
The Vanguard Group | 5,993,142 9.300% |
532,660 (+9.75%) |
Filing |
| 2021-02-10 10:57 am Sale |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
The Vanguard Group | 5,460,482 8.840% |
-10,980 (-0.20%) |
Filing |